Get the SPI Wire

Quoin Pharmaceuticals Ltd.

NASDAQ:QNRX
Annual Meeting

of Shareholders

MEETING DATE

08/20/2026
DEF 14A FILED
07/16/2026
PUBLISHED
07/16/2026 11:30 am
TIME TO PUBLISH
07/18/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:QNRX · CUSIP 74907L201 · CIK 0001671502

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

11
FOR
0
AGAINST
0
WITHHOLD
11
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1.A
To re-elect Dr. Michael Myers to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Dr. Michael Myers, and he consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.B
To re-elect Ms. Denise Carter to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Denise Carter, and she consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.C
To re-elect Mr. Joseph Cooper to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Joseph Cooper, and he consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.D
To re-elect Mr. James Culverwell to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated James Culverwell, and he consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.E
To re-elect Dr. Dennis H. Langer to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Dr. Dennis H. Langer, and he consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.F
To re-elect Ms. Natalie Leong to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Natalie Leong, and she consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1.G
To re-elect Mr. Michael Sember to serve as Director of the Company until the Company's next annual general meeting.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Michael Sember, and he consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve, by an advisory vote, the compensation of the Company's named executive officers, as described in the Proxy Statement, dated July 16, 2026.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states this is a non-binding advisory vote on named executive officer compensation.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve changes to the Company's non-employee directors' compensation program, as described in the Proxy Statement, dated July 16, 2026.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board approved the changes after receiving the Compensation Committee's recommendation.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve changes to the matching contributions payable pursuant to the Company’s 401(k) plan, including to the Company's U.S.-based executive officers.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states increased matching provisions would apply to all 401(k) Plan participants.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To appoint CBIZ CPAs P.C. to serve as the Company's auditor and independent registered public accounting firm until the Company's next annual general meeting of shareholders.
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states there were no disagreements or reportable events with Marcum.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

348844839d8443cf51a868364baaee9bf4450ca5f84f2f98c3d12121ef4cc1f6

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates